Renal nitric oxide production during the early phase of experimental diabetes mellitus

被引:60
作者
Keynan, S
Hirshberg, B
Levin-Iaina, N
Wexler, ID
Dahan, R
Reinhartz, E
Ovadia, H
Wollman, Y
Chernihovskey, T
Iaina, A
Raz, I
机构
[1] Hadassah Univ Hosp, Dept Internal Med, IL-91120 Jerusalem, Israel
[2] Hadassah Univ Hosp, Dept Neurol, IL-91120 Jerusalem, Israel
[3] Ichilov Hosp, Tel Aviv Med Ctr, Dept Nephrol, IL-64239 Tel Aviv, Israel
关键词
streptozotocin; renal hypertrophy; nephropathy; macula densa; neuronal nitric oxide synthase;
D O I
10.1046/j.1523-1755.2000.00220.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background. Diabetic nephropathy (DN) is characterized by hyperfiltration and hypertrophy in experimental models of diabetes mellitus (DM). Several studies have demonstrated that the pathophysiologic and morphologic changes in DN are mediated by either an increase or decrease in renal nitric oxide (NO) production and/or activity. The goal of the present study was to determine the effects that the early diabetic state has on NO production in the kidney of rats with streptozotocin-induced DM. Methods. Experimental DM was induced in rats with streptozotocin. Urinary NO production was measured, and levels and activity of the different NOS isoforms were determined by a combination of techniques, including immunoblotting, immunohistochemistry, diaphorase staining, and reverse transcription-polymerase chain reaction. Results. During the first week of DM, urinary NO metabolites (uNO(2) + NO3) were reduced as compared with controls, which were unrelated to changes in serum levels of NO. Total NO synthase (NOS) activity was reduced in the renal cortex beginning at 30 hours after the induction of DM. NADPH diaphorase staining of renal cortical slices showed reduced NOS activity in the macula densa in diabetic animals. By immunohistochemical staining with antibodies to the different isoforms of NOS, it was found that protein levels of the neuroneal NOS (nNOS) isoform was diminished in the macula densa. No changes were found in the levels of endothelial NOS (eNOS) activity and protein in the renal cortex in the early diabetic state. Conclusions. This study provides strong evidence that renal production of NO is reduced in early DM and that this reduction is associated with decreased levels of nNOS activity and protein in the macula densa.
引用
收藏
页码:740 / 747
页数:8
相关论文
共 39 条
  • [31] ROLE OF NITRIC-OXIDE (EDRF) IN RADIOCONTRAST ACUTE-RENAL-FAILURE IN RATS
    SCHWARTZ, D
    BLUM, M
    PEER, G
    WOLLMAN, Y
    MAREE, A
    SERBAN, I
    GROSSKOPF, I
    CABILI, S
    LEVO, Y
    IAINA, A
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1994, 267 (03): : F374 - F379
  • [32] RENAL HYPERTROPHY IN EXPERIMENTAL DIABETES - RELATION TO SEVERITY OF DIABETES
    SEYERHANSEN, K
    [J]. DIABETOLOGIA, 1977, 13 (02) : 141 - 143
  • [34] Increased expression of endothelial cell nitric oxide synthase (ecNOS) in afferent and glomerular endothelial cells is involved in glomerular hyperfiltration of diabetic nephropathy
    Sugimoto, H
    Shikata, K
    Matsuda, M
    Kushiro, M
    Hayashi, Y
    Hiragushi, K
    Wada, J
    Makino, H
    [J]. DIABETOLOGIA, 1998, 41 (12) : 1426 - 1434
  • [35] ABNORMAL RENAL HEMODYNAMIC-RESPONSE TO REDUCED RENAL PERFUSION-PRESSURE IN DIABETIC RATS - ROLE OF NO
    TOLINS, JP
    SHULTZ, PJ
    RAIJ, L
    BROWN, DM
    MAUER, SM
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 265 (06): : F886 - F895
  • [36] ATTENUATED GLOMERULAR CGMP PRODUCTION AND RENAL VASODILATION IN STREPTOZOTOCIN-INDUCED DIABETIC RATS
    WANG, YX
    BROOKS, DP
    EDWARDS, RM
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 264 (05): : R952 - R956
  • [37] Wardle EN, 1996, QJM-INT J MED, V89, P943
  • [38] Macula densa nitric oxide synthase: Expression, regulation, and function
    Wilcox, CS
    Welch, WJ
    [J]. KIDNEY INTERNATIONAL, 1998, 54 : S53 - S57
  • [39] Expression of nitric oxide synthase in macula densa in streptozotocin diabetic rats
    Yagihashi, N
    Nishida, N
    Seo, HG
    Taniguchi, N
    Yagihashi, S
    [J]. DIABETOLOGIA, 1996, 39 (07) : 793 - 799